Biolife Solutions Inc’s recent filing unveils that its Chief Human Resources Officer Aebersold Sarah unloaded Company’s shares for reported $70600.0 on Apr 01 ’24. In the deal valued at $17.65 per share,4,000 shares were sold. As a result of this transaction, Aebersold Sarah now holds 65,843 shares worth roughly $1.2 million.
Then, Berard Todd sold 515 shares, generating $9,265 in total proceeds. Upon selling the shares at $17.99, the Chief Marketing Officer now owns 139,644 shares.
Before that, Mathew Aby J. sold 454 shares. Biolife Solutions Inc shares valued at $8,167 were divested by the EVP & Chief Scientific Officer at a price of $17.99 per share. As a result of the transaction, Mathew Aby J. now holds 319,682 shares, worth roughly $5.81 million.
Jefferies initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on April 04, 2024; the price target was $22. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating. Oppenheimer also remained covering BLFS and has increased its forecast on April 25, 2022 with a “an Outperform” recommendation from previously “Perform” rating. B. Riley Securities started covering the stock on October 19, 2021. It rated BLFS as “a Buy”.
Price Performance Review of BLFS
On Tuesday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock jump 4.91% to $18.16. Over the last five days, the stock has gained 3.18%. Biolife Solutions Inc shares have risen nearly 11.75% since the year began. Nevertheless, the stocks have fallen -9.79% over the past one year. While a 52-week high of $24.50 was reached on 03/26/24, a 52-week low of $8.92 was recorded on 03/01/24. SMA at 50 days reached $17.71, while 200 days put it at $15.61. A total of 0.32 million shares were traded, compared to the trading of 0.33 million shares in the previous session.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 17.48, which if violated will result in even more drops to 16.80. On the upside, there is a resistance level at 18.66. A further resistance level may holdings at 19.16. The Relative Strength Index (RSI) on the 14-day chart is 54.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 48.57%. Stochastics %K at 30.26% indicates the stock is a holding.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on Mar 15, 2024, dropping by -0.52 million shares to a total of 3.03 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 3.55 million shares. There was a decline of -17.16%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 10.13% of the overall stock float, the days-to-cover ratio (short ratio) fell to 7.07.
